AAAAAA

   
Results: 1-10 |
Results: 10
ROLE OF SIGMOIDOSCOPY AND FECAL OCCULT BLOOD TESTING (FOBT) IN SCREENING FOR COLORECTAL-CANCER (CRC)
Authors: HELM JF SIMPSON KN SANDLER RS
Citation: Jf. Helm et al., ROLE OF SIGMOIDOSCOPY AND FECAL OCCULT BLOOD TESTING (FOBT) IN SCREENING FOR COLORECTAL-CANCER (CRC), Gastroenterology, 114(4), 1998, pp. 71-71
ASPIRIN AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS AND RISK FOR COLORECTAL ADENOMAS
Authors: SANDLER RS GALANKO JC MURRAY SC HELM JF WOOSLEY JT
Citation: Rs. Sandler et al., ASPIRIN AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS AND RISK FOR COLORECTAL ADENOMAS, Gastroenterology, 114(3), 1998, pp. 441-447
RISKS AND BENEFITS OF ASPIRIN THERAPY FOR PREVENTION OF COLORECTAL-CANCER (CRC) AND MYOCARDIAL-INFARCTION IN AVERAGE RISK MEN
Authors: RUSSO MW HELM JF RANSOHOFF DF SIMPSON K SANDLER RS
Citation: Mw. Russo et al., RISKS AND BENEFITS OF ASPIRIN THERAPY FOR PREVENTION OF COLORECTAL-CANCER (CRC) AND MYOCARDIAL-INFARCTION IN AVERAGE RISK MEN, Gut, 41, 1997, pp. 66-66
SCREENING FOR COLORECTAL-CANCER (CRC) BY FECAL OCCULT BLOOD TESTING (FOBT) IS COST-EFFECTIVE, BUT IS IT AFFORDABLE
Authors: HELM JF RUSSO MW SIMPSON KN RANSOHOFF DF SANDLER RS
Citation: Jf. Helm et al., SCREENING FOR COLORECTAL-CANCER (CRC) BY FECAL OCCULT BLOOD TESTING (FOBT) IS COST-EFFECTIVE, BUT IS IT AFFORDABLE, Gastroenterology, 112(4), 1997, pp. 18-18
WHAT DO WE GAIN BY SCREENING FOR COLORECTAL-CANCER (CRC) WITH 6 TESTSFOR FECAL OCCULT BLOOD, AND AT WHAT COST
Authors: HELM JF QUADE D RUSSO MW SIMPSON KN RANSOHOFF DF SANDLER RS
Citation: Jf. Helm et al., WHAT DO WE GAIN BY SCREENING FOR COLORECTAL-CANCER (CRC) WITH 6 TESTSFOR FECAL OCCULT BLOOD, AND AT WHAT COST, Gastroenterology, 112(4), 1997, pp. 576-576
SERIAL FECAL OCCULT BLOOD TESTING DETECTS MORE CANCERS AT A LOWER COST
Authors: RUSSO MW HELM JF BIDDLE AK SANDLER RS
Citation: Mw. Russo et al., SERIAL FECAL OCCULT BLOOD TESTING DETECTS MORE CANCERS AT A LOWER COST, Gastroenterology, 112(4), 1997, pp. 648-648
ASPIRIN AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS PREVENT COLORECTAL ADENOMAS
Authors: SANDLER RS GALANKO JA MURRAY SC HELM JF WOOSLEY JT
Citation: Rs. Sandler et al., ASPIRIN AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS PREVENT COLORECTAL ADENOMAS, Gastroenterology, 112(4), 1997, pp. 650-650
WEIGHING THE BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN PRIMARY PREVENTION OF COLORECTAL-CANCER (CRC)
Authors: RUSSO MW HELM JF SIMPSON KN RANSOHOFF DF WURZELMANN JI SANDLER RS
Citation: Mw. Russo et al., WEIGHING THE BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN PRIMARY PREVENTION OF COLORECTAL-CANCER (CRC), Gastroenterology, 110(4), 1996, pp. 36-36
THE GENETIC-BASIS OF SCALD RESISTANCE IN WESTERN CANADIAN BARLEY CULTIVARS
Authors: PENNER GA TEKAUZ A REIMER E SCOLES GJ ROSSNAGEL BG ECKSTEIN PE LEGGE WG BURNETT PA FERGUSON T HELM JF
Citation: Ga. Penner et al., THE GENETIC-BASIS OF SCALD RESISTANCE IN WESTERN CANADIAN BARLEY CULTIVARS, Euphytica, 92(3), 1996, pp. 367-374
PARADOXICAL INHIBITION OF MOTOR-ACTIVITY IN THE HUMAN CECUM AND APPENDIX AFTER A MEAL
Authors: HELM JF SARNA SK OTTERSON MF RYAN RP ARNDORFER RC
Citation: Jf. Helm et al., PARADOXICAL INHIBITION OF MOTOR-ACTIVITY IN THE HUMAN CECUM AND APPENDIX AFTER A MEAL, Gastroenterology, 104(4), 1993, pp. 520-520
Risultati: 1-10 |